Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128553) titled 'Safety and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV who had first-generation integrase strand transfer inhibitors resistance' on July 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Ditan Hospital, Capital Medical University
Condition:
HIV
Intervention:
Treatment-na?ve people living with HIV (antiretroviral therapy on BIC/FTC/TAF):None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-08-01
Target Sample Size: Treatment-na?ve people living with HIV (antiretroviral therapy on BIC/FTC/TAF):80;treatment...